Lexington BioSciences (CSE: LNB) (OTC: LXGTF) introduces HeartSentry, a revolutionary, simple and effective technology for personalized measurement and monitoring of vascular health to detect the potential for cardiovascular disease at its earliest stages. The device measures the function of the endothelium, the cells that line all arteries and are critical to the prevention of atherosclerosis, heart attacks and stroke.
View Top Employees from Lexington BioSciences Inc| Website | https://lexingtonbiosciences.com/ |
| Revenue | $1 million |
| Employees | 2 (0 on RocketReach) |
| Address | Suite 1900 – 1055 W. Hastings St., Vancouver, British Columbia V6E 2E9, CA |
| Phone | (604) 343-4547 |
| Technologies | |
| Industry | Medical Equipment Manufacturing, Medical Devices & Equipment, Monitoring Equipment, Manufacturing, Other Healthcare Technology Systems |
| SIC | SIC Code 384 Companies, SIC Code 38 Companies |
Looking for a particular Lexington BioSciences Inc employee's phone or email?
Lexington BioSciences Inc Questions
The Lexington BioSciences Inc annual revenue was $1 million in 2024.
Lexington BioSciences Inc is based in Vancouver, British Columbia.
The SIC codes for Lexington BioSciences Inc are [384, 38].
Related Companies
